Open-Label Study to Evaluate the Safety and Tolerability of Telaprevir in Combination With Sofosbuvir in Treatment Naive Subjects Chronically Infected With Hepatitis C Virus Genotype 1.

Trial Profile

Open-Label Study to Evaluate the Safety and Tolerability of Telaprevir in Combination With Sofosbuvir in Treatment Naive Subjects Chronically Infected With Hepatitis C Virus Genotype 1.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Telaprevir (Primary) ; Sofosbuvir
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Acronyms STEADFAST
  • Most Recent Events

    • 05 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 21 May 2014 According to ClinicalTrials.gov record. status changed from recruiting to active, no longer recruiting.
    • 15 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top